2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$12.63-$0.005 (-0.04%)
Price as of Jun 23, 2026 5:01 PM EDT- $279.3MMarket Cap
- 31.77%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$12.63-$0.005 (-0.04%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.63 | ||
Change | +$0.66 (+5.51%) | ||
Open | $11.88 | ||
High | $13.02 | ||
Low | $11.66 | ||
Previous Close | $11.97 | ||
Volume | 152,499 | ||
30-Day Average Volume | 146,834 | ||
1-Week Change | 1.53% | ||
1-Month Change | -27.66% | ||
1-Year Change | 31.77% | ||
3-Year Change | -80.63% | ||
5-Year Change | -96.18% | ||
Fundamentals | |||
Shares Outstanding | 23.3M | ||
Total Assets | $350.6M | ||
Market Cap | $279.3M | ||
Enterprise Value | $188.5M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$38.6M | ||
EBIT | -$24.2M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $230.4M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 94,270 | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue